OBJECTIVES: To assess a new method of determining functional impairment in @entity1 with @entity613 , the @entity69507 ( @entity69507 ) using the PADHOC ( @entity3657 Holter Control) device, against a standard treadmill test. DESIGN: @entity1 with @entity613 presenting to the department were considered for both the @entity69507 and a standard treadmill test. METHODS: initial claudicating distance, maximal walking distance and speed of walking were determined for both parts of the @entity69507 . Initial claudicating distance and maximal walking distance were determined from the treadmill test. Comparisons were made between the treadmill test and the @entity69507 . RESULTS: The treadmill test was unable to be performed in 22% of @entity1 due to defined contraindications. There were strong correlations in both walking distances and disease severity when comparing the @entity69507 and the treadmill test. @entity1 in whom the treadmill test was contraindicated had significantly shorter walking distances on the @entity69507 than those who were able to complete a treadmill walking test. CONCLUSIONS: The @entity69507 correlates strongly with walking distances obtained from a standard treadmill test. However, the PADHOC can be used in a number of differing locations and settings as well as in @entity1 in whom a treadmill test is contraindicated. It therefore has a role to play in the initial assessment of @entity1 presenting with @entity613 .

A new device for the measurement of disease severity in @entity1 with XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity613 :: ('MESH:D007383', 'Disease') :: ['intermittent claudication'] @entity69507 :: ('MESH:C538475', 'Disease') :: ['Double Physiological Walking Test', 'DPWT'] @entity3657 :: ('MESH:D058729', 'Disease') :: ['Peripheral Arterial Disease']
@entity613 :: (MESH:D007383,Disease) :: ['intermittent claudication']
